How to buy Marvell (MRVL) stock from India

Yes, an Indian resident can buy Marvell — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is easy. What decides your outcome is tax, estate-tax exposure, and position sizing. MRVL yields ~0.3%, so withholding and Form 67 are in scope but the dollar amounts are tiny — this is really a capital-gains story.

The 30-second version

• Legal and simple. Buy MRVL via Vested, INDmoney, IBKR, or Rovia. Whole shares or a fractional rupee amount.
• Capital-gains spine, tiny dividend. MRVL yields ~0.3%. 25% US WHT applies; Form 67 lets you claim credit in India, but the dollar amount is small. The real engine is capital appreciation.
• India tax: hold more than 24 months for 12.5% LTCG (no indexation); sell sooner and pay your slab rate. Section 112, not the friendlier 112A.
• The trap most miss: directly-held MRVL is a US-situs asset — above $60,000, the estate faces up to 40% US estate tax, no India-US treaty relief.
• If your thesis is "AI silicon," SMH and SOXX hold MRVL alongside Nvidia, Broadcom, TSMC, AMD — same theme, no single-name risk.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	MRVL / Nasdaq
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact rupee amount)
Dividend	Small, around 0.3% yield — 25% US WHT, recover via Form 67
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick Vested, INDmoney, IBKR, or Rovia. File your W-8BEN — drops US dividend WHT from 30% to the 25% treaty rate. New to this? See how to invest in US stocks from India.
2. Fund it via the LRS. Remit under the LRS (cap: $250,000 per FY). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. MRVL trades in the high double-digits to low triple-digits — whole share or fractional rupee amount.

The tax that actually matters

Marvell's dividend is small; 25% US WHT applies, you reclaim it as foreign tax credit via Form 67 — same mechanic as Microsoft or Apple, smaller dollar amounts. The real lever is capital gains at sale, under Section 112:

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 30 shares at $70, USD/INR 86 → cost 1,80,600 rupees. Sell 26 months later at $90, USD/INR 88 → proceeds 2,37,600 rupees. Gain 57,000 rupees; LTCG at 12.5% = 7,125 rupees. Gain is computed in rupees, so a weaker rupee at sale amplifies it. Model with the US capital-gains calculator; rules in how US stocks are taxed in India. Form 67 detail: dividend withholding and Form 67.

The $60,000 estate-tax trap

Directly-held MRVL is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — the India-US treaty does not cover estate tax, so no credit or relief. The fix (pooled or fund structures) has to be a deliberate choice before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Marvell through an ETF?

If you want…	Best route
A concentrated bet that MRVL beats other AI-silicon names	MRVL directly
"AI custom silicon and connectivity will keep winning" exposure	SMH or SOXX — Nvidia, Broadcom, TSMC, AMD, MRVL and more in one wrapper
Broad US-tech exposure with MRVL inside it	VTI or VOO — MRVL is held at a small weight
The least single-stock risk	A broad ETF

MRVL sits in VTI and VOO at a tiny weight. The cleaner play on AI silicon without single-name risk is a semi ETF: SMH (VanEck, ~25 names, Nvidia/TSMC/Broadcom-heavy) and SOXX (iShares, ~30 names, more balanced) both hold MRVL at a meaningful weight alongside the rest of the custom-silicon and connectivity stack. Compare routes in direct stocks vs US ETFs and best US ETFs for Indian investors; also US ETFs for Indians.

The business in one screen

What it is: Marvell is a data-infrastructure semi with two growth engines and two cyclical drags. Engine one: custom AI ASICs co-designed with hyperscalers — disclosed engagements on AWS Trainium2 and Google Axion, runway into 2027. Engine two: optical and connectivity — PAM4 DSPs, ZR coherent optics, and AEC that move data inside and between AI data centres. Storage and carrier/networking are the smaller drags.

Bull case	Bear case
Second pure-play AI-custom-silicon winner (after Broadcom)	Hyperscaler concentration — AWS, Google, Microsoft could vertically integrate
AWS Trainium2 and Google Axion disclosed, runway into 2027	Broadcom is the bigger ASIC incumbent and competes hard
Optical and PAM4 DSP demand scales with AI cluster build-out	Nvidia merchant roadmap could compress optical/DSP margins
ZR coherent and AEC extend connectivity TAM	Carrier/storage cyclical and dragging blended results
	TSMC allocation caps how fast custom ASICs ship

Exact valuation is in the live widget above — premium multiple, justified only if the custom-silicon ramp lands as guided.

Our take

Verdict: BUY — second pure-play winner of AI custom silicon, clear runway into 2027, and a real second leg in optical connectivity.

• Second pure-play custom-silicon winner. After Broadcom, MRVL is the cleanest listed way to own design-and-ship ASICs, with disclosed AWS Trainium2 and Google Axion engagements running into 2027. Hyperscalers are capacity-constrained, not demand-constrained.
• A real connectivity leg. PAM4 DSPs, ZR coherent optics, and AEC scale linearly with AI cluster build-outs — more GPUs and ASICs deployed means more interconnect shipped.
• Nearly pure capital-gains profile. Form 67 work exists but is trivial in dollars. Section 112 LTCG and position sizing matter far more.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Hyperscaler concentration. AWS, Google, Microsoft drive the ASIC story. If any slows orders, retargets a rival, or vertically integrates, the pipeline gaps fast.
• Broadcom and Nvidia. Broadcom competes for the same custom-ASIC sockets; Nvidia's merchant roadmap and growing networking/optical stack threaten the connectivity leg long-term.
• Capacity and cyclicality. TSMC allocation can cap shipments. Carrier and storage segments stay cyclical and drag the blended result.
• Currency: USD return, rupee spend — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose MRVL every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Tiny dividend receipts must be reported too. Use the Schedule FA helper.
• Position size: a high-multiple semi with hyperscaler concentration is not an index. Size MRVL as a high-conviction satellite, not a substitute for a broad ETF or SMH.

Bottom line

Buying MRVL from India is easy and legal. What needs thought is that MRVL is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap, and a premium-multiple semi with hyperscaler concentration that needs disciplined sizing. The small dividend adds a sliver of Form 67 work but doesn't change the math. If your thesis is "AI custom silicon and connectivity," SMH or SOXX gives the theme without single-name risk. Start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.